INTRAFRACTION PROSTATE MOTION MANAGEMENT

The raypilot system

Enabling accuracy in prostate cancer care

The Raypilot System is an electromagnetic positioning system that continuously localizes the prostate during radiation therapy. The system includes a transmitter which tracks the prostate tumour movements and outlines the urethra in real-time 3D, thus enhancing treatment precision and enabling a significant reduction of the risk of damaging surrounding healthy tissue. The precision makes it possible to use higher radiation dose and treatment may be given in a week or less, compared to conventional therapy over an 8-week period.

Learn more
+
Treated patients
+
Clinics served
+
Studies and posters

Healthcare professionals about Raypilot

“The reported significantly increased toxicity for SBRT vs standard IMRT was mostly urethra related. Having the possibility to identify the urethra using the Raypilot Hypocath gives us the opportunity to reduce the urethral dose without underdosing the tumour, thus delivering a safer treatment.”

Medical Physicist Denis Panizza, San Gerardo Hospital, Monza, Italy

LEARN MORE

“Raypilot Hypocath enables us to keep track of prostate motion during SBRT treatments where the precise dose to the target and strict tolerance to the surrounding organs is paramount.”

Professor Stefano Arcangeli, Head of Radiation Oncology, San Gerardo Hospital, Monza, Italy

LEARN MORE

”Raypilot is a game changer for our clinic. Being able to track tumour movements in real time reduces the margins and removes the uncertainty we previously felt about hypofractionation. It helps us treat more patients through hypofractionation. The results so far have been very promising.”

Professor Duncan McLaren, Consultant Clinical Oncologist, Edinburgh Cancer Centre, Western General Hospital, Scotland

LEARN MORE

”Very user-friendly system. Very easy to understand and supports us a lot in the standard workflow. This system has the potential to become a valuable asset when using SBRT protocols for treating prostate cancer.”

Professor Felix Sedlmayer, Department of Radiotherapy and Radio-Oncology, LKH Salzburg, Austria and Paracelsus Medical University, Salzburg, Austria

LEARN MORE

BENEFITS

OUTLINING OF URETHRA

REPRODUCIBILITY OF BLADDER FILLING

RIGHT DOSE DELIVERED TO RIGHT TARGET

PATIENT STORIES

– I have not had any side effects. My way of life hasn´t changed at all.

Mr Cattaneo Giorgio, treated at San Gerardo Hospital in Monza, Italy.

Meet 79-year-old Mr Cattaneo Giorgio. He was treated for prostate cancer in four sessions performed in four consecutive days. The use of Raypilot allows faster as well as more effective and safe treatments.

  • Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial

    Read article

latest publications

More Publications

Events

There are no upcoming events at this time

See More Events

Follow us on LinkedIn

Let’s keep in touch